Reece Pharmaceuticals scales up manufacturing

Synthetic antibiotic developer Recce Pharmaceuticals Ltd (ASX: RCE) has scaled up its Sydney production facility to support its commercialisation activities. The company, which has patented a new class of antibiotics to tackle resistant superbugs, has increased capacity at Macquarie Park in Sydney fivefold to cope with increasing demand. The Company has developed an automated process…